Drs. Andreas Vogt and Mark Schurdak have received NIH funding in collaboration with Haitao Guo in the Department of Microbiology & Molecular Genetics for the project: High throughput screening and preclinical development of HBV cccDNA inhibitors.
Drs. Andreas Vogt and Mark Schurdak have received NIH funding in collaboration with Haitao Guo in the Department of Microbiology & Molecular Genetics for the project: High throughput screening and preclinical development of HBV cccDNA inhibitors.